BIOMEDICAL INFORMATICS
生物医学信息学
基本信息
- 批准号:8436451
- 负责人:
- 金额:$ 15.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAlgorithmsAreaBioinformaticsBiological MarkersCancer Center Support GrantCollaborationsComputer softwareConsultCountryDataData AnalysesData Storage and RetrievalDevelopmentDoctor of PhilosophyEducational ActivitiesEngineeringFacultyGenerationsHigh Performance ComputingHome environmentHumanInformaticsInstitutesInstructionInvestmentsJournalsKaplan Cancer CenterMalignant NeoplasmsMedical InformaticsMedical centerMethodsModemsMolecular ProfilingPaperPathway interactionsPharmacologic SubstancePhylogenetic AnalysisPoliciesProceduresProteomicsPublic Health InformaticsPublishingQualifyingReportingResearchResearch InfrastructureResearch MethodologyResearch PersonnelResource SharingResourcesScienceServicesTimeTrainingWashingtonanticancer researchbasebiomedical informaticscost effectivehigh throughput screeninginformatics shared resourceinnovationmembermethod developmentnext generation sequencingnovelprogramstool
项目摘要
PROJECT SUMMARY (See instructions): The Biomedical Informatics Shared Resource (BISR), a new Shared Resource of the NYU Cancer Institute (NYUCI), aims to provide to all members of the NYUCI rapid, high-quality, and cost-effective access to state of- the-art and novel bioinformatics and medical informatics methods, tools, infrastructure and expert consulting/analyses as well as broader collaborative science opportunities with highly qualified informatics faculty. The BISR is leveraged by the launching and development since 2009 of the NYU Center for Health Informatics and Bioinformatics (CHIBI), which provides BISR with: a large and high-impact faculty with expertise in all aspects of bioinformatics and medical informatics; a High Performance Computing Facility (HPC), 7 informatics methods development labs, a full range of educational activities, full informatics support of high throughput assays, and the Best Practices Integrative Informatics Consulting core (BPIC) BISR will offer the following informatics services, and resources: BISR faculty and staff embedded in the NYUCI; dedicated NYUCI member access consulting faculty within a branch of BPIC specifically devoted to cancer research; dedicated access to HPC resources; and unlimited access to automated data analysis pipelines, software, best practices, educational and training seminars, courses and materials. BISR enforces diverse and strict QA operating procedures; it has numerous fruitful interactions with most NYUCI shared resources. Finally, BISR implements cost-effective chargeback and usage policies, is comprehensively advised by a User Advisory, and reports directly to the NYUCI director and executive advisory committee.
项目摘要(请参阅说明):NYU癌症研究所(Nyuci)的新共享资源(Nyuci)的生物医学信息学共享资源(BISR)旨在为Nyuci的所有成员提供快速,高质量和成本效益的所有成员,并有效地访问了ART和新型的生物信息和医学信息,并参与了InfrraS和新颖的方法,以下方面的工具,并参与了众多工具,并参与了众多工具,顾问,并与之构建,并参与了专家,并参与了良好的工具,始终如一地,并与之相关。具有高素质的信息学院。自2009年纽约大学健康信息学和生物信息学中心(Chibi)以来,BISR的发射和开发都被发射和开发所利用,该中心为BISR提供了:一个大型且高影响力的教师在生物信息学和医学信息学各个方面具有专业知识;高性能计算设施(HPC),7种信息学方法开发实验室,全面的教育活动,对高吞吐量测定的全面信息学支持以及最佳实践综合信息咨询核心(BPIC)BISR将提供以下信息学服务和资源:BISR教师和员工在nyci中的恩典;专门专门致力于癌症研究的BPIC分支机构内的Nyuci成员访问咨询学院;专用访问HPC资源;无限制地访问自动数据分析管道,软件,最佳实践,教育和培训研讨会,课程和材料。 BISR执行多样化和严格的质量检查操作程序;它与大多数Nyuci共享资源有许多富有成果的互动。最后,BISR实施了具有成本效益的拒绝和使用政策,并由用户咨询提供了全面的建议,并直接向Nyuci董事和执行咨询委员会报告。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William L. Carroll其他文献
The Role of over-Expressed β <em>Globin</em> in Driving Relapsed B - Cell Acute Lymphoblastic Leukemia (B-ALL)
- DOI:
10.1182/blood-2023-180976 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Jessica Krugman;Sylwia Jasinski;Elizabeth A. Raetz;Nikki Evensen;William L. Carroll - 通讯作者:
William L. Carroll
Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231
- DOI:
10.1182/blood-2023-190141 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Susan I. Colace;Meenakshi Devidas;Zhiguo (Bruce) Chen;Robert J. Hayashi;Brent L. Wood;Natia Esiashvili;Samir Patel;Andrew J Carroll;Nyla A. Heerema;Barbara Asselin;Karen R. Rabin;Patrick A. Zweidler-McKay;Elizabeth A. Raetz;Mignon L. Loh;Naomi J. Winick;William L. Carroll;David T. Teachey;Stuart S. Winter;Kimberly P. Dunsmore - 通讯作者:
Kimberly P. Dunsmore
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
- DOI:
10.1182/blood-2024-194872 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Etan Orgel;Michael J. Burke;John A. Kairalla;Emily Hibbitts;Meenakshi Devidas;Michael J. Borowitz;Brent L. Wood;Nyla A. Heerema;Andrew J. Carroll;Kelly Maloney;Leonard A. Mattano;Anne Angiolillo;Eric C. Larsen;Wanda L. Salzer;David T. Teachey;Naomi J. Winick;William L. Carroll;Stephen P. Hunger;Elizabeth A. Raetz;Mignon L. Loh - 通讯作者:
Mignon L. Loh
<em>Subtype Dependent Drug Resistance Alterations in Relapsed Childhood B-ALL: A Children's Oncology Group Study</em>
- DOI:
10.1182/blood-2022-166489 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Xiaotu Ma;Lingyun Ji;Yanling Liu;Ying Shao;Heather Mulder;Pandurang Kolekar;Quang Tran;Jinghui Zhang;John Easton;William L. Carroll;Patrick A. Brown;Mignon L. Loh - 通讯作者:
Mignon L. Loh
Patients with Down Syndrome and High-Risk B-Acute Lymphoblastic Leukemia Demonstrate Improved Outcomes on a Modified Chemotherapy Regimen: A Report from Children's Oncology Group Study AALL1131
- DOI:
10.1182/blood-2023-185368 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Vilmarie Rodriguez;Meenakshi Devidas;Zhiguo (Bruce) Chen;Andrew J Carroll;Nyla A. Heerema;Michael J. Borowitz;Brent L. Wood;William L. Carroll;Naomi J Winick;Elizabeth A. Raetz;Mignon L. Loh;Michael J. Burke;Wanda L. Salzer;Stephen P. Hunger;Karen R. Rabin - 通讯作者:
Karen R. Rabin
William L. Carroll的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William L. Carroll', 18)}}的其他基金
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
- 批准号:
10381569 - 财政年份:2021
- 资助金额:
$ 15.75万 - 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
- 批准号:
10184002 - 财政年份:2021
- 资助金额:
$ 15.75万 - 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
- 批准号:
10631888 - 财政年份:2021
- 资助金额:
$ 15.75万 - 项目类别:
相似国自然基金
无界区域中非局部Klein-Gordon-Schrödinger方程的保结构算法研究
- 批准号:12301508
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
感兴趣区域驱动的主动式采样CT成像算法研究
- 批准号:62301532
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
面向多区域单元化生产线协同调度问题的自动算法设计研究
- 批准号:62303204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于深度强化学习的约束多目标群智算法及多区域热电调度应用
- 批准号:62303197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向二氧化碳封存的高可扩展时空并行区域分解算法及其大规模应用
- 批准号:12371366
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
相似海外基金
Probing synaptic and circuit mechanisms of hippocampal plasticity with all-optical electrophysiology
用全光电生理学探讨海马可塑性的突触和回路机制
- 批准号:
10644885 - 财政年份:2023
- 资助金额:
$ 15.75万 - 项目类别:
Revealing the role of blood microbiome in childhood asthma
揭示血液微生物组在儿童哮喘中的作用
- 批准号:
10590805 - 财政年份:2023
- 资助金额:
$ 15.75万 - 项目类别:
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
病毒多样性是改进艾滋病毒发病率估计的创新生物标志物
- 批准号:
10676203 - 财政年份:2022
- 资助金额:
$ 15.75万 - 项目类别:
Elucidating the pharmacogenetics of the response to GLP-1 receptor agonists for type 2 diabetes
阐明 GLP-1 受体激动剂治疗 2 型糖尿病反应的药物遗传学
- 批准号:
10524795 - 财政年份:2022
- 资助金额:
$ 15.75万 - 项目类别:
Elucidating the pharmacogenetics of the response to GLP-1 receptor agonists for type 2 diabetes
阐明 GLP-1 受体激动剂治疗 2 型糖尿病反应的药物遗传学
- 批准号:
10689328 - 财政年份:2022
- 资助金额:
$ 15.75万 - 项目类别: